Literature DB >> 28325822

Structural basis for chemokine recognition by a G protein-coupled receptor and implications for receptor activation.

Joshua J Ziarek1, Andrew B Kleist1, Nir London2, Barak Raveh3, Nicolas Montpas4,5, Julien Bonneterre4,5, Geneviève St-Onge5, Crystal J DiCosmo-Ponticello6, Chad A Koplinski1, Ishan Roy7, Bryan Stephens8, Sylvia Thelen9, Christopher T Veldkamp10, Frederick D Coffman11, Marion C Cohen6, Michael B Dwinell7, Marcus Thelen9, Francis C Peterson1, Nikolaus Heveker4,5, Brian F Volkman12.   

Abstract

Chemokines orchestrate cell migration for development, immune surveillance, and disease by binding to cell surface heterotrimeric guanine nucleotide-binding protein (G protein)-coupled receptors (GPCRs). The array of interactions between the nearly 50 chemokines and their 20 GPCR targets generates an extensive signaling network to which promiscuity and biased agonism add further complexity. The receptor CXCR4 recognizes both monomeric and dimeric forms of the chemokine CXCL12, which is a distinct example of ligand bias in the chemokine family. We demonstrated that a constitutively monomeric CXCL12 variant reproduced the G protein-dependent and β-arrestin-dependent responses that are associated with normal CXCR4 signaling and lead to cell migration. In addition, monomeric CXCL12 made specific contacts with CXCR4 that are not present in the structure of the receptor in complex with a dimeric form of CXCL12, a biased agonist that stimulates only G protein-dependent signaling. We produced an experimentally validated model of an agonist-bound chemokine receptor that merged a nuclear magnetic resonance-based structure of monomeric CXCL12 bound to the amino terminus of CXCR4 with a crystal structure of the transmembrane domains of CXCR4. The large CXCL12:CXCR4 protein-protein interface revealed by this structure identified previously uncharacterized functional interactions that fall outside of the classical "two-site model" for chemokine-receptor recognition. Our model suggests a mechanistic hypothesis for how interactions on the extracellular face of the receptor may stimulate the conformational changes required for chemokine receptor-mediated signal transduction.
Copyright © 2017, American Association for the Advancement of Science.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28325822      PMCID: PMC5648539          DOI: 10.1126/scisignal.aah5756

Source DB:  PubMed          Journal:  Sci Signal        ISSN: 1945-0877            Impact factor:   8.192


  73 in total

1.  The Xplor-NIH NMR molecular structure determination package.

Authors:  Charles D Schwieters; John J Kuszewski; Nico Tjandra; G Marius Clore
Journal:  J Magn Reson       Date:  2003-01       Impact factor: 2.229

2.  Structure-based ligand discovery for the protein-protein interface of chemokine receptor CXCR4.

Authors:  Michael M Mysinger; Dahlia R Weiss; Joshua J Ziarek; Stéphanie Gravel; Allison K Doak; Joel Karpiak; Nikolaus Heveker; Brian K Shoichet; Brian F Volkman
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-19       Impact factor: 11.205

3.  Crystal structure of recombinant human stromal cell-derived factor-1alpha.

Authors:  Eui Kyung Ryu; Tae Gyun Kim; Taek Hun Kwon; In Duk Jung; Dowook Ryu; Yeong-Min Park; Junhong Kim; Kyo Han Ahn; Changill Ban
Journal:  Proteins       Date:  2007-06-01

4.  Recognition of a CXCR4 sulfotyrosine by the chemokine stromal cell-derived factor-1alpha (SDF-1alpha/CXCL12).

Authors:  Christopher T Veldkamp; Christoph Seibert; Francis C Peterson; Thomas P Sakmar; Brian F Volkman
Journal:  J Mol Biol       Date:  2006-05-11       Impact factor: 5.469

Review 5.  Macromolecular modeling with rosetta.

Authors:  Rhiju Das; David Baker
Journal:  Annu Rev Biochem       Date:  2008       Impact factor: 23.643

6.  The structural basis of peptide-protein binding strategies.

Authors:  Nir London; Dana Movshovitz-Attias; Ora Schueler-Furman
Journal:  Structure       Date:  2010-02-10       Impact factor: 5.006

7.  A novel peptide antagonist of CXCR4 derived from the N-terminus of viral chemokine vMIP-II.

Authors:  N Zhou; Z Luo; J Luo; J W Hall; Z Huang
Journal:  Biochemistry       Date:  2000-04-04       Impact factor: 3.162

8.  Comparison of the potential multiple binding modes of bicyclam, monocylam, and noncyclam small-molecule CXC chemokine receptor 4 inhibitors.

Authors:  Rebecca S Y Wong; Veronique Bodart; Markus Metz; Jean Labrecque; Gary Bridger; Simon P Fricker
Journal:  Mol Pharmacol       Date:  2008-09-02       Impact factor: 4.436

9.  Signal transmission through the CXC chemokine receptor 4 (CXCR4) transmembrane helices.

Authors:  Melanie P Wescott; Irina Kufareva; Cheryl Paes; Jason R Goodman; Yana Thaker; Bridget A Puffer; Eli Berdougo; Joseph B Rucker; Tracy M Handel; Benjamin J Doranz
Journal:  Proc Natl Acad Sci U S A       Date:  2016-08-19       Impact factor: 11.205

10.  Crystal structure of the β2 adrenergic receptor-Gs protein complex.

Authors:  Søren G F Rasmussen; Brian T DeVree; Yaozhong Zou; Andrew C Kruse; Ka Young Chung; Tong Sun Kobilka; Foon Sun Thian; Pil Seok Chae; Els Pardon; Diane Calinski; Jesper M Mathiesen; Syed T A Shah; Joseph A Lyons; Martin Caffrey; Samuel H Gellman; Jan Steyaert; Georgios Skiniotis; William I Weis; Roger K Sunahara; Brian K Kobilka
Journal:  Nature       Date:  2011-07-19       Impact factor: 49.962

View more
  37 in total

1.  Evaluation and extension of the two-site, two-step model for binding and activation of the chemokine receptor CCR1.

Authors:  Julie Sanchez; Zil E Huma; J Robert Lane; Xuyu Liu; Jessica L Bridgford; Richard J Payne; Meritxell Canals; Martin J Stone
Journal:  J Biol Chem       Date:  2018-12-19       Impact factor: 5.157

2.  Functional anatomy of the full-length CXCR4-CXCL12 complex systematically dissected by quantitative model-guided mutagenesis.

Authors:  Bryan S Stephens; Tony Ngo; Irina Kufareva; Tracy M Handel
Journal:  Sci Signal       Date:  2020-07-14       Impact factor: 8.192

3.  Comparative modeling and docking of chemokine-receptor interactions with Rosetta.

Authors:  Michael J Wedemeyer; Benjamin K Mueller; Brian J Bender; Jens Meiler; Brian F Volkman
Journal:  Biochem Biophys Res Commun       Date:  2020-01-07       Impact factor: 3.575

4.  The chemokine X-factor: Structure-function analysis of the CXC motif at CXCR4 and ACKR3.

Authors:  Michael J Wedemeyer; Sarah A Mahn; Anthony E Getschman; Kyler S Crawford; Francis C Peterson; Adriano Marchese; John D McCorvy; Brian F Volkman
Journal:  J Biol Chem       Date:  2020-08-11       Impact factor: 5.157

5.  Structure-function guided modeling of chemokine-GPCR specificity for the chemokine XCL1 and its receptor XCR1.

Authors:  Jamie C Fox; Monica A Thomas; Acacia F Dishman; Olav Larsen; Takashi Nakayama; Osamu Yoshie; Mette Marie Rosenkilde; Brian F Volkman
Journal:  Sci Signal       Date:  2019-09-03       Impact factor: 8.192

6.  In Silico Studies Targeting G-protein Coupled Receptors for Drug Research Against Parkinson's Disease.

Authors:  Agostinho Lemos; Rita Melo; Antonio Jose Preto; Jose Guilherme Almeida; Irina Sousa Moreira; Maria Natalia Dias Soeiro Cordeiro
Journal:  Curr Neuropharmacol       Date:  2018       Impact factor: 7.363

Review 7.  Advances in therapeutic peptides targeting G protein-coupled receptors.

Authors:  Anthony P Davenport; Conor C G Scully; Chris de Graaf; Alastair J H Brown; Janet J Maguire
Journal:  Nat Rev Drug Discov       Date:  2020-03-19       Impact factor: 84.694

Review 8.  Structural basis of chemokine and receptor interactions: Key regulators of leukocyte recruitment in inflammatory responses.

Authors:  Ram Prasad Bhusal; Simon R Foster; Martin J Stone
Journal:  Protein Sci       Date:  2019-10-24       Impact factor: 6.725

9.  Mapping Interaction Sites on Human Chemokine Receptors by Deep Mutational Scanning.

Authors:  Jeremiah D Heredia; Jihye Park; Riley J Brubaker; Steven K Szymanski; Kevin S Gill; Erik Procko
Journal:  J Immunol       Date:  2018-04-20       Impact factor: 5.422

10.  Modeling the complete chemokine-receptor interaction.

Authors:  Michael J Wedemeyer; Benjamin K Mueller; Brian J Bender; Jens Meiler; Brian F Volkman
Journal:  Methods Cell Biol       Date:  2018-11-01       Impact factor: 1.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.